```html

Kawasaki Disease Fever

What is Kawasaki disease fever?

Kawasaki disease (KD) is an acute, self‑limited vasculitis that primarily affects children under five years of age. A hallmark of the illness is a **prolonged high fever** that lasts at least five days and does not respond to typical antipyretics. The fever signals inflammation of medium‑sized arteries, especially the coronary arteries, and can be the first clue that the disease is present.

Because the symptoms overlap with many common childhood infections, KD is sometimes called “mucocutaneous lymph node syndrome.” Early recognition of the fever pattern and accompanying signs is crucial—untreated KD can lead to coronary artery aneurysms, myocardial infarction, or sudden cardiac death.

Sources: Mayo Clinic, CDC.

Common Causes

While the exact trigger of Kawasaki disease remains unknown, the fever that characterizes it can be precipitated or mimicked by several other conditions. Knowing these helps clinicians differentiate KD from other illnesses.

• Viral infections – adenovirus, influenza, enterovirus, and Epstein–Barr virus.
• Bacterial infections – Staphylococcus aureus, Streptococcus pyogenes, and atypical Mycoplasma pneumoniae.
• Scarlet fever – caused by group A Streptococcus, produces fever and a sandpaper rash.
• Staphylococcal or streptococcal toxic shock syndrome – rapid fever with rash and hypotension.
• Systemic juvenile idiopathic arthritis – persistent fever with joint inflammation.
• Incomplete or atypical Kawasaki disease – fever without the full set of classic signs.
• Drug reactions (e.g., Stevens‑Johnson syndrome) – can cause fever and mucocutaneous lesions.
• Rocky Mountain spotted fever – tick‑borne illness presenting with fever, rash, and headache.
• Measles or rubella – viral exanthems that include fever and conjunctival injection.
• Autoimmune vasculitides – such as polyarteritis nodosa, which may present with fever and arterial inflammation.

Identifying the correct cause guides treatment and reduces the risk of missed KD.

Associated Symptoms

In Kawasaki disease, the fever is usually accompanied by a constellation of clinical findings. At least four of the following five principal features are required for a classic diagnosis:

• Conjunctival injection – bilateral, non‑purulent redness of both eyes without discharge.
• Oral mucosal changes – "strawberry tongue," cracked lips, and erythema of the oral cavity.
• Peripheral extremity changes – erythema of the palms/soles, swelling of hands and feet, followed by desquamation (peeling) after 2–3 weeks.
• Polymorphous rash – may be maculopapular, erythema multiforme‑like, or scarlatiniform.
• Cervical lymphadenopathy – usually a single node >1.5 cm, often tender.

Additional findings that can appear during the acute phase include:

• Joint pain or swelling (arthralgia/arthritis)
• Gallbladder hydrops or abdominal pain
• irritability or mood changes
• Cardiac involvement (myocarditis, pericarditis)
• Elevated liver enzymes or mild jaundice

These extra‑cardiac signs help differentiate KD from simple febrile viral illnesses.

When to See a Doctor

Because untreated KD can cause irreversible heart damage, parents and caregivers should seek medical evaluation promptly if the following occur:

• Fever lasting ≥ 5 days that does not improve with acetaminophen or ibuprofen.
• Any two of the classic KD signs (conjunctivitis, oral changes, rash, extremity changes, lymphadenopathy) together with the fever.
• Sudden swelling or pain in the hands/feet, especially if the skin begins to peel.
• Persistent irritability, especially in a toddler who cannot verbalize discomfort.
• New onset chest pain, shortness of breath, or palpitations – possible early cardiac involvement.

Early referral to a pediatrician, emergency department, or pediatric cardiology service is recommended.

Diagnosis

Diagnosing Kawasaki disease remains primarily clinical, supported by laboratory and imaging studies.

1. Clinical criteria

The American Heart Association (AHA) defines classic KD as fever ≥ 5 days plus ≥ 4 of the 5 principal features. “Incomplete” KD is considered when fever is present with 2–3 features but supportive lab/imaging findings exist.

2. Laboratory tests

• Complete blood count – often reveals elevated white blood cells (neutrophilia), anemia, and thrombocytosis (platelets rise after day 7).
• Inflammatory markers – C‑reactive protein (CRP) > 3 mg/dL and erythrocyte sedimentation rate (ESR) > 40 mm/hr are typical.
• Liver enzymes – mild elevations in AST/ALT.
• Urinalysis – sterile pyuria (white cells without bacteria) is common.
• Serum electrolytes – hyponatremia may be seen.

3. Cardiac imaging

• Echocardiogram – first‑line test to evaluate coronary artery dimensions, aneurysms, and ventricular function. It is performed at diagnosis, 1–2 weeks later, and again at 6–8 weeks.
• Electrocardiogram (ECG) – looks for arrhythmias or ST‑segment changes.
• CT coronary angiography or cardiac MRI – reserved for equivocal echocardiograms or when detailed anatomy is needed.

4. Exclusion of mimicking diseases

Doctors will order cultures, viral PCR panels, or serologies to rule out bacterial sepsis, scarlet fever, measles, and other infectious etiologies.

Treatment Options

Timely therapy reduces the risk of coronary aneurysms from ~25 % to <5 %.

1. Intravenous immunoglobulin (IVIG)

• Standard dose: 2 g/kg infused over 10–12 hours.
• Most effective when given within the first 10 days of fever.
• Reduces inflammation and protects coronary arteries.

2. Aspirin

• High‑dose phase: 30–50 mg/kg/day divided every 6 hours until the fever resolves (usually 48–72 hours).
• Low‑dose (anti‑platelet) phase: 3–5 mg/kg/day once daily for 6–8 weeks, or longer if coronary abnormalities persist.
• Monitor for signs of aspirin toxicity (gastrointestinal bleeding, tinnitus).

3. Adjunctive anti‑inflammatory therapy

For patients who do not respond to the initial IVIG dose (≈10‑20 % of cases), options include:

• Second IVIG dose – repeat 2 g/kg.
• Corticosteroids – oral prednisolone 2 mg/kg/day or pulse methylprednisolone 30 mg/kg/day for 1–3 days.
• Infliximab (anti‑TNFα) – 5 mg/kg IV infusion, especially in IVIG‑resistant disease.
• Other biologics – e.g., anakinra (IL‑1 receptor antagonist) under specialist care.

4. Supportive & home care measures

• Fever control with acetaminophen (avoid NSAIDs until aspirin therapy is started).
• Maintain hydration – encourage fluids, especially if fever is high.
• Skin care – gentle moisturizers for cracked lips and peeling skin; avoid harsh soaps.
• Regular follow‑up appointments for cardiac monitoring.

Prevention Tips

Since the precise cause of Kawasaki disease is unknown, primary prevention is limited, but families can adopt general measures that may lower the risk of triggering infections that can mimic or exacerbate KD:

• Hand‑washing with soap for at least 20 seconds, especially after diaper changes or contact with sick individuals.
• Keep up-to-date on childhood immunizations (flu, measles, varicella, etc.).
• Avoid exposure to known sick contacts during peak viral seasons.
• Prompt treatment of bacterial infections to reduce systemic inflammation.
• Educate caregivers about the typical KD fever pattern and warning signs.

There is no vaccine or specific prophylactic medication for KD.

Emergency Warning Signs

Key Take‑aways

• Kawasaki disease fever is a prolonged high fever (≥ 5 days) that signals systemic vasculitis.
• Diagnosis relies on clinical criteria, lab markers of inflammation, and cardiac imaging.
• IVIG plus aspirin within the first 10 days dramatically lowers the risk of coronary aneurysms.
• Watch for red‑flag symptoms—especially cardiac or neurologic changes—and obtain care promptly.
• Long‑term follow‑up with pediatric cardiology is essential for children who develop coronary changes.

For more detailed information, consult reputable sources such as the Mayo Clinic, CDC, and the American Heart Association Guidelines.

```